Cargando…
Re: ‘Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes mellitus: a meta-analysis’
Autor principal: | Philip, Sephy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949876/ https://www.ncbi.nlm.nih.gov/pubmed/36845767 http://dx.doi.org/10.1097/MS9.0000000000000002 |
Ejemplares similares
-
RETRACTED: Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes
mellitus: A meta-analysis
por: Sattar, Yasar, et al.
Publicado: (2022) -
The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl
por: Steg, Ph Gabriel, et al.
Publicado: (2021) -
Effect of Concomitant Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on the Pharmacokinetics of Atorvastatin
por: Braeckman, Rene A., et al.
Publicado: (2014) -
Eicosapentaenoic acid ethyl ester improves endothelial dysfunction in type 2 diabetic mice
por: Takenouchi, Yasuhiro, et al.
Publicado: (2018) -
Effect of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Omeprazole Plasma Pharmacokinetics in Healthy Adults
por: Braeckman, Rene A., et al.
Publicado: (2014)